Health experts in Aotearoa New Zealand are confident that cervical cancer can be eradicated through a combination of vaccination, screening, and treatment, aligning with the World Health Organization’s (WHO) 2030 global target to eliminate it as a public health issue. Currently, approximately 175 New Zealanders are diagnosed with cervical cancer annually, with around 55 deaths reported each year. While the 2030 deadline remains ambitious, researchers suggest that with widespread action, elimination could be achievable by 2038, particularly through the expansion of primary HPV screening and addressing disparities in vaccination rates.
The WHO defines elimination as fewer than four cervical cancer cases per 100,000 women annually. This goal hinges on reducing the prevalence of human papillomavirus (HPV), the primary cause of cervical cancer, which is transmitted through sexual contact. Professor Bev Lawton, founder of Te Tātai Hauora o Hine at Victoria University of Wellington, emphasizes that HPV is preventable, and eliminating it requires a multi-pronged approach. “There’s highly few things in health that, if you get the job done, we’ve eliminated it,” she says, highlighting the potential for Aotearoa to lead the way in cervical cancer prevention.
The government’s nationwide rollout of primary HPV screening in 2023 marks a significant shift in detection strategies. Unlike traditional Pap smears, this method tests directly for HPV, the virus that often precedes cancer. The self-testing kits, resembling at-home COVID-19 tests, allow individuals to collect samples discreetly. For Alice Hyatt, a Nelson resident, this technology proved lifesaving. In 2023, her HPV test detected the high-risk strain HPV18, prompting further investigation that revealed early-stage cancer. “You’ve basically saved your own life just by going to have that one swab,” her gynaecologist told her, underscoring the power of proactive screening.
However, screening alone is not enough. The HPV vaccine, introduced in New Zealand’s national schedule in 2008, has been critical in preventing infection. Free for all genders aged 9–27, the vaccine has significantly reduced HPV prevalence. Yet, challenges persist, particularly among Māori communities. According to Cancer Society CEO Nicola Coom, HPV vaccination rates for Māori children under 15 stand at 51%, about 9–10% lower than for non-Māori. “There’s a whole lot of things we can be doing there,” she says, pointing to systemic barriers such as access, cultural awareness, and trust in healthcare systems.
To address these gaps, the Cancer Society has outlined a roadmap in its recent political manifesto, calling for full funding of the national screening program, a dedicated National Cervical Cancer Elimination Action Plan, and increased investment in HPV immunization campaigns. The organization has also partnered with Te Tātai Hauora o Hine to amplify efforts. “That’s gonna be a big few years. But there’s nothing more important than saving these wahine’s lives,” Coom emphasizes.
The path forward requires not only policy changes but also community engagement. For Māori, who face higher cervical cancer incidence rates, culturally responsive education and outreach are essential. “Elimination won’t be without its obstacles,” acknowledges Coom, but she remains optimistic. “What we have is a matter of health equity, and it’s within our power to make it a reality.”
As Aotearoa moves toward its 2038 target, the integration of technology, education, and collaboration will be key. The success of programs like HPV screening and vaccination demonstrates the potential for collective action. Yet, the road ahead demands sustained commitment to close gaps in access and ensure that no community is left behind. For now, stories like Hyatt’s offer a glimpse of what is possible when prevention meets persistence.
Follow Our Changing World on Apple, Spotify, or iHeartRadio for more insights into health and innovation in Aotearoa. Sign up for the monthly newsletter to explore deeper stories behind the science and policy shaping our future.
